Research
Metabolic adaptation
Prior GLP-1 agonist use is not associated with ICU length of stay in critically ill patients.
Clinicians may determine that prior GLP-1 agonist use does not affect ICU length of stay for critically ill patients.
StrongRefutesmedium confidence
The matched GLP-1 agonist and comparison groups showed similar ICU length of stay (5.9 ± 9.0 vs. 5.4 ± 6.6 days, MD: 0.51, 95% CI: -0.52 to 1.50, p = .33).
Why this rating
Based on a large cohort study design with propensity matching.
Source
Prior GLP‐1 agonist use is not associated with adverse inpatient critical care outcomes: A propensity‐matched analysis
Albert K. Park et al. · Journal of Hospital Medicine · 2025
cohort · n=15191Cited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →